Home » Newsletters » BioWorld Science

BioWorld Science

July 22, 2005

View Archived Issues

Salivary bacteria species predict oral squamous cell carcinoma

Hydroxyurea reduces vascular event risk more than anagrelide in essential thrombocythemia

Gene therapy-induced angiogenesis shows promise for treating cardiovascular disease

Erlotinib lengthens survival in previously treated non-small cell lung cancer

Aphios collaborates with Japanese companies on paclitaxel prodrug

Epix Pharmaceuticals to amend phase II protocols for EP-2104R

CX-3543 begins phase I cancer trial

Encouraging early data from phase I/II study of AV-201 for Parkinson's disease

HIV protease inhibitor 640385 receives fast track designation

Hemospan begins new phase II surgical blood loss trial

Phase III program studies tenofovir disoproxil fumarate for chronic hepatitis B

FDA requests more information to complete NE-180 IND review

InterMune and Array BioPharma expand HCV collaboration

Alkermes and Lilly begin phase III study of inhaled insulin system

Novartis receives U.S. clearance to complete acquisition of Eon Labs

New phase II trial for Imvamune in HIV patients

Genzyme launches minimal residue disease test for B-CLL

Toyama Chemical begins U.S. phase I study of T-817MA

Celecoxib reported safe when given to NSCLC patients on thoracic radiotherapy

Update on the antitumor effects of Xyotax in NSCLC

Phase II data show OSI-211 not effective enough in recurrent small cell lung cancer

L-BLP-25 improves survival in advanced NSCLC patients

Structure disclosed for TPI-287

Mitsubishi launches argatroban as first solely marketed product in Europe

Novel cannabinoid CB1/CB2 receptor modulators emerge from Solvay R&D

Therapeutic agents for hepatitis C infection claimed

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...